Paragon 28, Inc.

    Paragon 28, Inc.

    NNYSE:FNA
    13.09
    USD
    0.00
    (0.00%)
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    2024 Y
    TTM
    Revenue per Share
    1.58
    1.65
    1.93
    2.33
    2.64
    - -
    3.08
    Basic EPS, GAAP
    0.05
    0.04
    -0.18
    -0.84
    -0.7
    - -
    -0.66
    Free Cash Flow per Basic Share
    -0.09
    -0.14
    -0.32
    -1.19
    -1.12
    - -
    -0.53
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    0.15
    0.19
    - -
    -0.84
    -1.5
    - -
    -2.13
    Tangible Book Value per Share
    0.31
    0.4
    2.22
    1.22
    1.49
    - -
    1.02
    Basic Weighted Avg Shares
    67
    67
    76
    78
    82
    - -
    83
    Sales/Revenue/Turnover
    106
    111
    147
    181
    216
    256
    256
    Operating Margin (%)
    2.56
    1.87
    -7.31
    -19.13
    -21.1
    -15.92
    -15.92
    Depreciation Expense
    4
    6
    9
    14
    16
    19
    19
    Net Income, GAAP
    3
    3
    -14
    -66
    -58
    -55
    -55
    Effective Tax Rate (%)
    - -
    30.39
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    2.93
    3.15
    -9.29
    -36.19
    -26.59
    -21.33
    -21.33
    Working Capital
    4
    50
    146
    74
    157
    121
    121
    LT Debt
    - -
    4
    7
    42
    110
    110
    110
    Total Equity
    27
    71
    192
    143
    170
    131
    131
    Return on Invested Capital (%)
    - -
    2.31
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    8.29
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)
    - -
    23.66
    -207.71
    - -
    - -
    - -
    - -

    Capital Structure

    USD

    •

    in mil. unless spec.
    Jun'24
    Sep'24
    Dec'24
    ST Debt
    1
    1
    1
    LT Borrowings
    110
    110
    110
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    84
    84
    84
    Market Capitalization
    567
    556
    859

    Working Capital

    USD

    •

    in mil. unless spec.
    Jun'24
    Sep'24
    Dec'24
    Total Current Assets
    184
    178
    169
    Cash, Cash Equivalents & STI
    47
    39
    35
    Accounts Receivable, Net
    37
    36
    39
    Inventories
    96
    96
    90
    Total Current Liabilities
    52
    51
    48
    Payables & Accruals
    50
    49
    37
    ST Debt
    1
    1
    1
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    USD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    60.27%
    -23.06%
    Free Cash Flow
    - -
    89.02%
    -52.03%
    Net Income, GAAP
    - -
    -23.44%
    -5.03%
    Sales/Revenue/Turnover
    - -
    19.6%
    18.39%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    41
    42
    46
    52
    181
    2023
    52
    51
    53
    61
    216
    2024
    61
    61
    62
    72
    256

    Quarterly Earnings Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    -0.12
    -0.13
    -0.13
    -0.5
    -0.84
    2023
    -0.13
    -0.16
    -0.14
    - -
    -0.7
    2024
    -0.21
    -0.17
    -0.15
    - -
    - -

    Quarterly Dividends Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -

    Company Description

    Address
    Similar Companies
    Business

    Company News

    • Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Paragon 28, Inc. (FNA) And Encourages Investors to Reach Out

    • Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Paragon 28, Inc. (FNA) And Encourages Stockholders to Reach Out

    • Bronstein, Gewirtz & Grossman, LLC Is Investigating Paragon 28, Inc. (FNA) And Encourages Stockholders to Connect

    • Paragon 28, Inc. (FNA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

    • Bronstein, Gewirtz & Grossman, LLC Encourages Paragon 28, Inc. (FNA) Shareholders to Inquire about Securities Investigation

    • Bronstein, Gewirtz & Grossman, LLC Is Investigating Paragon 28, Inc. (FNA) And Encourages Shareholders to Connect

    • Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Paragon 28, Inc. (FNA) And Encourages Shareholders to Reach Out

    • Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Paragon 28, Inc. (FNA) and Encourages Shareholders to Learn More About the Investigation

    • Bronstein, Gewirtz & Grossman, LLC Encourages Paragon 28, Inc. (FNA) Stockholders to Inquire about Securities Investigation

    • Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Paragon 28, Inc. (FNA) and Encourages Investors to Learn More About the Investigation

    • Paragon 28, Inc. (FNA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

    • Bronstein, Gewirtz & Grossman, LLC Is Investigating Paragon 28, Inc. (FNA) And Encourages Investors to Connect

    • Bronstein, Gewirtz & Grossman, LLC Encourages Paragon 28, Inc. (FNA) Stockholders to Inquire about Securities Investigation

    • Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Paragon 28, Inc. (FNA) And Encourages Stockholders to Reach Out

    • Bronstein, Gewirtz & Grossman, LLC Is Investigating Paragon 28, Inc. (FNA) And Encourages Stockholders to Connect

    • Paragon 28, Inc. (FNA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

    • Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Paragon 28, Inc. (FNA) and Encourages Stockholders to Learn More About the Investigation

    • Bronstein, Gewirtz & Grossman, LLC Encourages Paragon 28, Inc. (FNA) Investors to Inquire about Securities Investigation

    • Hip Implant Maker Zimmer Biomet Cuts Annual Profit Forecast On Paragon 28 Deal

    • Bronstein, Gewirtz & Grossman, LLC Encourages Paragon 28, Inc. (FNA) Shareholders to Inquire about Securities Investigation